Catalyst Wire Dossier Catalyst Wire Dossier

Narsoplimab

narsoplimab · Omeros Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Narsoplimab, covering 2025-03-25 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Single Patient Expanded Access Treatment Plan For The Investigational Product Narsoplimab

See pricing